282 related articles for article (PubMed ID: 34551979)
1. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
Aggarwal RK; Luchtel RA; Machha V; Tischer A; Zou Y; Pradhan K; Ashai N; Ramachandra N; Albanese JM; Yang JI; Wang X; Aluri S; Gordon S; Aboumohamed A; Gartrell BA; Hafizi S; Pullman J; Shenoy N
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551979
[TBL] [Abstract][Full Text] [Related]
2. Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis.
Yang J; Zhou Y; Li Y; Hu W; Yuan C; Chen S; Ye G; Chen Y; Wu Y; Liu J; Wang Y; Du J; Tong X
Bioengineered; 2022 Apr; 13(4):11187-11207. PubMed ID: 35510387
[TBL] [Abstract][Full Text] [Related]
3. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.
Shenoy N; Bhagat TD; Cheville J; Lohse C; Bhattacharyya S; Tischer A; Machha V; Gordon-Mitchell S; Choudhary G; Wong LF; Gross L; Ressigue E; Leibovich B; Boorjian SA; Steidl U; Wu X; Pradhan K; Gartrell B; Agarwal B; Pagliaro L; Suzuki M; Greally JM; Rakheja D; Thompson RH; Susztak K; Witzig T; Zou Y; Verma A
J Clin Invest; 2019 Mar; 129(4):1612-1625. PubMed ID: 30702441
[TBL] [Abstract][Full Text] [Related]
5. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
6. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
7. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.
Li J; Liang N; Long X; Zhao J; Yang J; Du X; Yang T; Yuan P; Huang X; Zhang J; He X; Xing J
Cancer Lett; 2019 Oct; 461():44-55. PubMed ID: 31278950
[TBL] [Abstract][Full Text] [Related]
8.
Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss.
Liu X; Simon JM; Xie H; Hu L; Wang J; Zurlo G; Fan C; Ptacek TS; Herring L; Tan X; Li M; Baldwin AS; Kim WY; Wu T; Kirschner MW; Gong K; Zhang Q
Mol Cell; 2020 Mar; 77(6):1294-1306.e5. PubMed ID: 32023483
[TBL] [Abstract][Full Text] [Related]
10. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
[TBL] [Abstract][Full Text] [Related]
11. Succinate Dehydrogenase-Deficient Renal Cancer Featuring Fructose-1,6-Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case Report.
Szymanski M; Rusetska N; Jancewicz I; Armatowska A; Ligaj M; Chrzan A; Hincza K; Kowalik A; Mika P; Kisiel M; Zolnierek J; Kosior J; Demkow T; Siedlecki JA; Sarnowski TJ; Sarnowska E
Oncologist; 2021 Sep; 26(9):e1652-e1655. PubMed ID: 34003534
[TBL] [Abstract][Full Text] [Related]
12. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
[TBL] [Abstract][Full Text] [Related]
13.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
14. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4.
Liu Y; Jiao D; Tian Z
Mol Med Rep; 2019 Jan; 19(1):711-718. PubMed ID: 30431118
[TBL] [Abstract][Full Text] [Related]
16. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract][Full Text] [Related]
17. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
Agaimy A
Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
[TBL] [Abstract][Full Text] [Related]
19. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
[TBL] [Abstract][Full Text] [Related]
20. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
